Publications
View AllNivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
Among patients with advanced nonsquamous NSCLC that had progressed during or after platinum-based chemotherapy, overall survival was longer with nivolumab than with docetaxel. (...
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer
Pembrolizumab led to significantly longer progression-free survival than chemotherapy when received as first-line therapy for MSI-H-dMMR metastatic colorectal cancer, with fewer...
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Progression-free survival was significantly longer with avelumab plus axitinib than with sunitinib among patients who received these agents as first-line treatment for advanced ...
The landscape of cancer genes and mutational processes in breast cancer
All cancers carry somatic mutations in their genomes. A subset, known as driver mutations, confer clonal selective advantage on cancer cells and are causally implicated in oncog...
Multifactorial Analysis of Differences Between Sporadic Breast Cancers and Cancers Involving BRCA1 and BRCA2 Mutations
Our study has identified key features of the histologic phenotypes of breast cancers in carriers of mutant BRCA1 and BRCA2 genes. This information may improve the classification...
Affiliated Researchers
Institution Info
- Type
- nonprofit
- Country
- FR
- Publications
- 9
- Citations
- 30,550
External Links
Identifiers
- ROR
- https://ror.org/01cmnjq37